Back to News
Market Impact: 0.35
GE HealthCare Adds SOFIE Biosciences In $945M Radiopharma Deal
Source: Nasdaq
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
GE HealthCare agreed to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expanding its presence in the U.S. radiopharmaceutical market. The article provides no expected financial impact or transaction completion date.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
GEHC0.55
More News
- Samsung, SK Hynix shares drop as Q3 earnings loom
- CH Robinson to Buy RXO for $5.8B in Bet on AI Model
- BPCE acquires 7% stake in Spain’s Banco Sabadell
- Wells Fargo gets a bold upgrade ahead of earnings. Why the stock can play catch-up
- Brazil Election: Bolsonaro Pushes Lula to Brink as Markets Set to Rally
- SpaceX stock climbs to highest since June, returning Musk to trillionaire status